CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Transurethral Resection of the Prostate (TURP)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03936244
NCT03936244N/ACompleted
CompareCT.gov

Randomized Controlled Trial Comparing Bipolar Plasmakinetic Transurethral Resection of the Prostate With Monopolar Transurethral Resection of the Prostate in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Hospital Universitario de Fuenlabrada·interventional·Posted May 3, 2019·Updated Nov 12, 2020

In Brief

A clinical study evaluating Transurethral Resection of the Prostate (TURP) for Prostatic Hyperplasia and 2 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Randomized controlled trial with one-year follow-up comparing intra, peri and postoperative outcomes for plasmakinetic transurethral resection of prostate (PK-TURP) and monopolar transurethral resection of prostate (M-TURP) in the treatment of LUTS due to BPH in a tertiary-care public institution

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatic Hyperplasia, Lower Urinary Tract Symptoms, Transurethral Resection of Prostate
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 3, 2019
Enrollment StartDec 5, 2014
Primary CompletionDec 12, 2017
Study CompletionDec 12, 2019
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.2 years ago

Interventions

Transurethral Resection of the Prostate (TURP)device

Randomized allocation to M-TURP or PK-TURP